AIP
MRNS

Ameritas Investment Partners’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Ameritas Investment Partners’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,249
Closed -$47.5K – 3288
2024
Q1 		$47.5K Hold
5,249
– – ﹤0.01% 2181
2023
Q4 		$57.1K Buy
5,249
+1,135
+28% +$8.51K ﹤0.01% 2097
2023
Q3 		$33.1K Hold
4,114
– – ﹤0.01% 2315
2023
Q2 		$44.7K Buy
+4,114
New +$35.2K ﹤0.01% 2122
2022
Q2 		– Sell
-2,896
Closed -$27K – 3289
2022
Q1 		$27K Hold
2,896
– – ﹤0.01% 2430
2021
Q4 		$34K Hold
2,896
– – ﹤0.01% 2379
2021
Q3 		$33K Hold
2,896
– – ﹤0.01% 2428
2021
Q2 		$52K Buy
2,896
+527
+22% +$8.48K ﹤0.01% 2158
2021
Q1 		$37K Buy
2,369
+581
+32% +$8.4K ﹤0.01% 2266
2020
Q4 		$22K Hold
1,788
– – ﹤0.01% 2430
2020
Q3 		$23K Sell
1,788
-1
-0.1% -$9 ﹤0.01% 2309
2020
Q2 		$18K Buy
1,789
+920
+106% +$8.46K ﹤0.01% 2401
2020
Q1 		$7K Hold
869
– – ﹤0.01% 2713
2019
Q4 		$8K Hold
869
– – ﹤0.01% 2818
2019
Q3 		$5K Hold
869
– – ﹤0.01% 2945
2019
Q2 		$14K Hold
869
– – ﹤0.01% 2662
2019
Q1 		$15K Hold
869
– – ﹤0.01% 2542
2018
Q4 		$10K Hold
869
– – ﹤0.01% 2680
2018
Q3 		$35K Hold
869
– – ﹤0.01% 2193
2018
Q2 		$25K Buy
+869
New +$19.3K ﹤0.01% 2395

Other funds holding MRNS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameritas Investment Partners's MRNS Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2024, closing a stake of 5,249 shares — an estimated $47.5K sold.

Ameritas Investment Partners first reported a position in MRNS in Q2 2018 and held it in 20 quarters. The position peaked at $57.1K in Q4 2023. 90 funds tracked by Wall St. Rank hold MRNS as of Q2 2024.

  • Ameritas Investment Partners reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 5,249 Marinus Pharmaceuticals, Inc shares in Q2 2024, an estimated $47.5K.
  • Ameritas Investment Partners first reported a position in Marinus Pharmaceuticals, Inc in Q2 2018 and held it in 20 quarters.
  • Ameritas Investment Partners's Marinus Pharmaceuticals, Inc position peaked at $57.1K in Q4 2023.
  • 90 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.